Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
DarioHealth Corp. (NASDAQ: DRIO)
DRIO Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
41.90%
Analyst Rating:
BUY
Analyst Forecast (1yr):
-31.40%
DRIO Stock Analysis
DRIO
PE Ratio:
DRIO
PEG Ratio:
Not Available
DRIO
Forward EPS Growth (12 month):
0.00%
DRIO
PS Ratio:
2.6
DRIO
PSG Ratio:
0.1
DRIO
Forward Revenue Growth (12 month):
46.10%
DRIO Articles
No data was found